Tetraphenyltin | CAS:595-90-4

We serve Tetraphenyltin CAS:595-90-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Tetraphenyltin

Chemical Name:Tetraphenyltin
CAS.NO: 595-90-4
Molecular Formula:C24H20Sn
Molecular Weight: 427.126
 
Synonyms:
Tetraphenyltin
Stannane, tetraphenyl-
Tetraphenylstannane
 
Physical and Chemical Properties:
Density :1.49 g/cm3
Boiling point :474.3±28.0 °C at 760 mmHg
Melting point: 223-229ºC
Flash point :241.6±11.1 °C
 
Specification:
Appearance: Off-white crystal powder
Purity: ≥97.5%
Loss on drying:≤0.2%
 
 
Packing:N.W.25kg/carton drum with plastic lining bag
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from light.
Application:chemical catalyst



Contact us for information like Tetraphenyltin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tetraphenylstannane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tetraphenyltin Use and application,Stannane, tetraphenyl- technical grade,usp/ep/jp grade.


Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.4-Methoxypyridine manufacturer The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.2-BROMOETHYL ISOTHIOCYANATE supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.Hydroxy Tyrosol α-Acetate vendor In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.